ASHLEE HOUSER: Open Payments
NPI 1285477851 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $244 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $200 |
| ABBVIE INC. | 4 | $93 |
| Novo Nordisk Inc | 3 | $83 |
| GlaxoSmithKline, LLC. | 3 | $69 |
| Exact Sciences Corporation | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
Products named: BREZTRI, UBRELVY, Ozempic, TRELEGY ELLIPTA, AIRSUPRA, FARXIGA, QULIPTA, The Cologuard Plus Collection Kit.
Industry payments across NY — which companies pay providers there.
